Hiroyoshi Maeda

Determinants of sensitivity and resistance to gemcitabine: The roles of human equilibrative nucleoside transporter 1 and deoxycytidine kinase in non‐small cell lung cancer

Hiroyuki Achiwa, Tetsuya Oguri, Shigeki Sato et al. · Cancer Science · 2004 · 145 citations · Full text

Medicine, Oncology, Pharmacology +14

MRP8/ABCC11 directly confers resistance to 5-fluorouracil

Tetsuya Oguri, Yuji Bessho, Hiroyuki Achiwa et al. · Molecular Cancer Therapeutics · 2007 · 131 citations

Medicine, Oncology, Pharmacology +15

The determinants of sensitivity and acquired resistance to gemcitabine differ in non–small cell lung cancer: a role of <i>ABCC5</i> in gemcitabine sensitivity

Tetsuya Oguri, Hiroyuki Achiwa, Shigeki Sato et al. · Molecular Cancer Therapeutics · 2006 · 99 citations

Medicine, Oncology, Pharmacology +15

<i>MRP7/ABCC10</i>expression is a predictive biomarker for the resistance to paclitaxel in non-small cell lung cancer

Tetsuya Oguri, Hiroaki Ozasa, Takehiro Uemura et al. · Molecular Cancer Therapeutics · 2008 · 76 citations · Full text

Medicine, Oncology, Pharmacology +14

The role of thymidylate synthase and dihydropyrimidine dehydrogenase in resistance to 5-fluorouracil in human lung cancer cells

Tetsuya Oguri, Hiroyuki Achiwa, Yuji Bessho et al. · Lung Cancer · 2005 · 64 citations

Medicine, Molecular Biology, Oncology +10